| Duration of adjuvant chemotherapy for stage III colon cancer A Grothey, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, ... New England Journal of Medicine 378 (13), 1177-1188, 2018 | 1041 | 2018 |
| Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi … J Garcia-Aguilar, LA Renfro, OS Chow, Q Shi, XW Carrero, PB Lynn, ... The lancet oncology 16 (15), 1537-1546, 2015 | 448 | 2015 |
| Non-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer JC Jones, LA Renfro, HO Al-Shamsi, AB Schrock, A Rankin, BY Zhang, ... Journal of Clinical Oncology 35 (23), 2624-2630, 2017 | 386 | 2017 |
| Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples LA Renfro, DJ Sargent Annals of Oncology 28 (1), 34-43, 2017 | 275 | 2017 |
| Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the adjuvant … MA Shah, LA Renfro, CJ Allegra, T André, A De Gramont, HJ Schmoll, ... Journal of Clinical Oncology 34 (8), 843-853, 2016 | 186 | 2016 |
| Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program CH Lieu, LA Renfro, A De Gramont, JP Meyers, TS Maughan, ... Journal of Clinical Oncology 32 (27), 2975-2982, 2014 | 175 | 2014 |
| Body mass index is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD database LA Renfro, F Loupakis, RA Adams, MT Seymour, V Heinemann, ... Journal of Clinical Oncology 34 (2), 144-150, 2016 | 143 | 2016 |
| CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer S Shiovitz, MM Bertagnolli, LA Renfro, E Nam, NR Foster, ... Gastroenterology 147 (3), 637-645, 2014 | 139 | 2014 |
| Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon … Q Shi, AF Sobrero, AF Shields, T Yoshino, J Paul, J Taieb, I Sougklakos, ... Journal of Clinical Oncology 35 (18_suppl), LBA1-LBA1, 2017 | 114 | 2017 |
| Personalizing survival predictions in advanced colorectal cancer: the ARCAD nomogram project KM Sjoquist, LA Renfro, RJ Simes, NC Tebbutt, S Clarke, MT Seymour, ... JNCI: Journal of the National Cancer Institute 110 (6), 638-648, 2018 | 110 | 2018 |
| Clinical trial designs incorporating predictive biomarkers LA Renfro, H Mallick, MW An, DJ Sargent, SJ Mandrekar Cancer treatment reviews 43, 74-82, 2016 | 85 | 2016 |
| ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer LA Renfro, A Grothey, Y Xue, LB Saltz, T André, C Twelves, R Labianca, ... Journal of the National Cancer Institute 106 (12), dju333, 2014 | 81 | 2014 |
| Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients G Srivastava, LA Renfro, RJ Behrens, M Lopatin, C Chao, GS Soori, ... The oncologist 19 (5), 492-497, 2014 | 76 | 2014 |
| Precision oncology: a new era of cancer clinical trials LA Renfro, MW An, SJ Mandrekar Cancer letters 387, 121-126, 2017 | 75 | 2017 |
| Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer NR Foster, LA Renfro, SE Schild, MW Redman, XF Wang, SE Dahlberg, ... Journal of Thoracic Oncology 10 (7), 1099-1106, 2015 | 50 | 2015 |
| On the need to adjust for multiplicity in confirmatory clinical trials with master protocols N Stallard, S Todd, D Parashar, PK Kimani, LA Renfro Annals of Oncology 30 (4), 506-509, 2019 | 45 | 2019 |
| Determinants of early mortality among 37,568 patients with colon cancer who participated in 25 clinical trials from the adjuvant colon cancer endpoints database WY Cheung, LA Renfro, D Kerr, A De Gramont, LB Saltz, A Grothey, ... Journal of Clinical Oncology 34 (11), 1182-1189, 2016 | 44 | 2016 |
| Clinical calculator for early mortality in metastatic colorectal cancer: an analysis of patients from 28 clinical trials in the Aide et Recherche en Cancérologie Digestive Database LA Renfro, RM Goldberg, A Grothey, A Sobrero, R Adams, MT Seymour, ... Journal of Clinical Oncology 35 (17), 1929-1937, 2017 | 42 | 2017 |
| Definitions and statistical properties of master protocols for personalized medicine in oncology LA Renfro, SJ Mandrekar Journal of biopharmaceutical statistics 28 (2), 217-228, 2018 | 39 | 2018 |
| Bayesian adjusted R2 for the meta‐analytic evaluation of surrogate time‐to‐event endpoints in clinical trials LA Renfro, Q Shi, DJ Sargent, BP Carlin Statistics in medicine 31 (8), 743-761, 2012 | 39 | 2012 |
